Close Menu

NEW YORK (360Dx) – PerkinElmer disclosed that it paid $219.8 million for its acquisition of Cisbio Bioassays, a custom assay service provider based in Codolet, France. PerkinElmer made the disclosure earlier this month in its Form 10Q filed with the US Securities and Exchange Commission.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.